Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1370
| Despition | EFEMP1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1765 | Human PQBP1 Protein (AC1765) | 5 µg | inquiry |
| ACPP-1047 | Recombinant Human Myelin Basic Protein Protein (Fc Tag) (AC1047) | 50 µg | inquiry |
| ACPP-1149 | Recombinant Human TNF Receptor II Protein (Fc Tag) (AC1149) | 50 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1111 | Recombinant Human NRG1 Protein (Fc Tag) (AC1111) | 50 µg | inquiry |
| ACPP-1140 | Recombinant Human CCR5 Protein (Fc Tag) (AC1140) | 50 µg | inquiry |
| ACPP-1534 | Human RLN3 Protein (AC1534) | 5 µg | inquiry |
| ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
| ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.